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Objectives: The CEAP (clinical, etiologic, anatomic, pathophysiologic) clinical classification for chronic venous disease
(CVD) is based on physician-evaluated clinical signs of CVD. The relationship between CEAP clinical classification and
patient-perceived quality of life (QOL) has not been evaluated, but is important for the selection and interpretation of
outcomes in clinical studies of patients with CVD. The purpose of this study was to evaluate whether CVD, as classified
with CEAP, is related to patient-reported QOL, and to identify patient characteristics associated with CEAP class and
QOL that need to be considered when interpreting outcomes in CVD.
Methods: The Venous Insufficiency Epidemiologic and Economic Study (VEINES) population is an international cohort
of 1531 patients with CVD recruited in Belgium, France, Italy, and Canada. At the baseline visit patients were categorized
into one of seven CEAP clinical categories on the basis of a clinical examination, and completed standardized generic
(Short-Form Health Survey, 36 items [SF-36]) and venous disease–specific (QOL [VEINES-QOL] and symptom
severity [VEINES-Sym]) QOL questionnaires. Multivariate analyses were used to examine the relationship between
CEAP class and QOL.
Results: The proportion of patients in the seven CEAP classes (class 0-6) was 3.8%, 13.3%, 24.1%, 12.8%, 36.4%, 7.3%, and
2.3%, respectively. In univariate analyses, SF-36 Physical Component Summary scores and VEINES-QOL and VEINES-
Sym scores decreased significantly (ie, poorer QOL) with increasing CEAP class. Multivariate analyses controlling for age,
sex, country, education, body mass index, years since CVD onset and comorbid conditions confirmed findings for
VEINES-QOL and VEINES-Sym (P < .0001 and P < .0001, respectively).
Conclusions: Physician-evaluated clinical category, based on the CEAP classification, predicts patient-reported QOL and
symptom severity in CVD. (J Vasc Surg 2004;39:823-8.)Chronic venous disease (CVD) is a highly prevalent
condition that affects many millions of persons worldwide
and incurs high costs for treatment.1-3 In a recent popula-
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doi:10.1016/j.jvs.2003.12.007tion-based study the incidence of CVD was almost 1 in
1000 persons per year, which translates into at least
150,000 new cases in the United States annually, at an
estimated cost of close to half a billion dollars.2
Progress in CVD research has been hampered by a lack
of consistency in terminology and in definition of CVD
severity. In an attempt to standardize reporting in CVD
research the CEAP (clinical, etiologic, anatomic, patho-
physiologic) classification system was proposed in 1995.4 It
has since been used in a number of clinical investigations to
classify CVD clinical presentation and to measure change in
CVD over time.
Increasingly, patient-reported quality of life (QOL) is
an important component in evaluating outcome, particu-
larly changes in illness severity over time. For chronic
conditions such as CVD, assessment of QOL can provide
important information regarding burden of illness that may
not be adequately captured with traditional physician-
based measures of morbidity or mortality.5-8 It is not
known whether physician-assessed CEAP clinical class ac-
curately reflects patients’ own perceptions of CVD severity.
This is important for the selection and interpretation of
outcomes in clinical studies of patients with CVD.823
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ship between clinically evaluated CEAP class and patient-
reported QOL. This will provide further validity evidence
by comparing the clinical and patient-based measures. We
also aimed to identify demographic and clinical character-
istics associated with CEAP class and QOL and that need to
be considered when interpreting outcomes in CVD.
METHODS
Study design. The Venous Insufficiency Epidemio-
logic and Economic Study (VEINES) was an international
prospective cohort study carried out from 1994 to 1997.9
Its main objective was to describe and compare clinical
presentations of CVD with regard to natural history, QOL,
health care usage, risk factors, and clinical outcomes. Sec-
ondary objectives were to develop or identify instruments
for the study of venous disease and to test their measure-
ment properties.8 Sampling of the study population was
based on a prospective registration of 5688 consecutive
outpatients from 18 to 75 years of age who consulted 166
general practitioners and 116 specialists (vascular surgeons,
phlebologists, angiologists) in Belgium, Canada, France,
and Italy. Data recorded at registration included age, sex,
and symptoms and signs of CVD. Registered patients at
each clinical site were organized into a sampling frame in
which all male patients and patients with ulcers were at the
top of the list, followed by all other registered patients in
random order. Study coordinators then randomly selected
study patients from the registered patient sampling frame
until target sample sizes were achieved. Male patients and
patients with ulcers were deliberately oversampled. Patients
were excluded if they had other conditions associated with
leg edema, such as right-sided congestive heart failure,
nephrotic syndrome, or limb paralysis; had a life-threaten-
ing illness or a serious psychiatric disorder that would
preclude follow-up; or had a language barrier, had no
telephone, or did not provide consent.
Patients who consented to participate were invited to a
baseline visit, which consisted of a medical interview and
physical examination of the lower extremities by the clini-
cian. To obtain independent evaluations of patient-re-
ported QOL and physician-evaluated clinical severity,
Fig 1. Distribution of CEAP clinical class in the Venous Insuffi-
ciency Epidemiologic and Economic Study population (n 
1531).QOL questionnaires were mailed to patients for comple-
tion before the baseline visit.
Approval was obtained from the relevant research eth-
ics committees in each country, and written informed con-
sent was obtained from all patients before study entry.
Medical interview. At the baseline visit the following
data were documented: age, gender, body mass index
(BMI), country, level of education (grade school only, high
school only, college or university), years since onset of
CVD, and three nonmutually exclusive comorbidity vari-
ables, including edema-related comorbidity (conditions
that may be associated with lower limb swelling, eg, heart
disease, obstructive lung disease, chronic renal disease,
hypothyroidism, lymphedema), arthroses-related comor-
bidity (conditions associated with lower limb pain, eg,
arthritis, other musculoskeletal conditions that affect lower
limbs), and “other” comorbidity (conditions unlikely to
produce leg symptoms).
Physical examination and clinical classification. At
the baseline visit the participating physician examined the
patient’s legs and classified the clinical category of CVD
according to the clinical component (C) of the CEAP
classification,4 which categorizes patients into one of seven
classes on the basis of clinical signs: class 0, no visible or
palpable signs of venous disease (ie, symptoms only); class
1, telangiectasias or reticular veins; class 2, varicose veins;
class 3, edema; class 4, skin changes due to venous disease;
class 5, skin changes with healed ulceration; and class 6, skin
changes with active ulceration. With this classification, se-
verity and type of symptom are not considered. Each cate-
Table I. Characteristics of study participants
No. of
patients n %
Age (y; mean  SD) 1531 54.0  13.8
Sex 1531
Male 340 22.2
Female 1191 77.8
Country 1531
Belgium 484 31.6
France 593 38.7
Italy 359 23.4
Canada 95 6.2
Body mass index (kg/m2;
mean  SD)
1488 26.1  5.0
Education (n  1353)
Grade school 287 21.2
High school 667 49.3
College or higher 399 29.5
Years since onset of venous
disorder
1452
1 30 2.1
1–4 240 16.5
5–9 241 16.6
10 941 64.8
Comorbid conditions
(% affected)
1514
Edema-related 623 41.1
Arthrosis-related 483 31.9
Other 341 22.5
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example, edema could be present in classes 4 through 6. If
both legs were affected, the highest class was recorded.
Quality of life and patient-reported symptoms.
Standardized, self-administered generic and disease-
specific instruments were used to measure generic and
venous disease-specific QOL. These included the Short-
Form Health Survey, 36 items (SF-36),10 and the
VEINES-QOL,8 respectively. The SF-36 is the current
generic standard measure of physical (SF-36 Physical Com-
ponent Summary [PCS]) and mental (SF-36 Mental Com-
ponent Summary [MCS]) QOL. The VEINES-QOL is a
26-item questionnaire that measures 10 venous symptoms,
including heavy legs, aching legs, swelling, night cramps,
heat or burning sensation, restless legs, throbbing, itching,
tingling, intensity of leg pain; limitations in daily activities
as a result of CVD (9 items), psychologic effect of CVD (5
items), change over the past year (1 item), and time of day
leg problems are most intense (1 item). The VEINES-Sym
is a validated subscale of the VEINES-QOL that measures
venous symptoms. The four language versions (English,
French, French Canadian, Italian) of the VEINES-QOL
have been comprehensively evaluated, and are acceptable,
reliable, valid, and responsive.8
Statistical analysis. SAS software (SAS Institute,
Cary, NC) was used for all analyses. Baseline characteristics
were tabulated for the study population as a whole and by
CEAP clinical class. Standard statistical tests (Pearson 2
test and analysis of variance) were used to compare fre-
quency distributions and mean values of patient variables
by clinical category. The Jonckheere-Terpstra nonparamet-
Table II. Baseline characteristics by CEAP class
No. of
patients
Class 0
(n  58)
Class 1
(n  204) (
Age (y; mean  SD) 1531 44.3  12.5 43.4  12.3 50
(%) Female sex 1531 78 95
Country (%) 1531
Belgium 21 22
France 41 44
Italy 29 19
Canada 9 15
Body mass index
(mean  SD)
1488 24.7  3.4 23.0  3.4 2
Education (%) 1353
Grade school 6 7
High school 66 40
College or higher 28 53
Years since onset of
CVD (%)
1452
1 5 3
1–4 33 27
5–9 20 28
10 42 42
Comorbid conditions
(% affected)
1531
Edema-related 18 21
Arthrosis-related 16 22
Other 11 6ric test for trend, as provided by the SAS PROC FREQ
procedure, was used to test whether mean QOL scores
differed across CEAP classes. For polychotomous variables,
the Pearson 2 test was used to test for differences in the
frequency distribution of CEAP classes. To prevent poor
approximations to the 2 distribution owing to the pres-
ence of sparse cells, the Monte Carlo option provided by
SAS software was used to estimate the exact P values when
observed cell counts were less than 10.
To examine the common effect of potential explana-
tory variables, including CEAP clinical class, on QOL,
multivariate regression analyses were performed with a
generalized linear model with log-link. For all models the
independent variables were CEAP clinical class and the
clinical variables of interest listed above. In separate models
the dependent variable was one of four QOL scores: SF-36
MCS, SF-36 PCS, VEINES-QOL, or VEINES-Sym. Al-
though interaction effects between years since onset of
CVD and the other independent variables were suspected,
these were not confirmed with the Akaike information
criterion (AIC) to determine the best fit.
Because of missing values, sample size was reduced in
models that included education (n  1353), years since
onset of CVD (n  1452), and BMI (n  1482). For
missing data on QOL questionnaires, the standard meth-
od11 for imputing a person-specific estimate where the
respondent answered at least 50% of the items in a scale was
used; otherwise, data for the whole questionnaire were
considered missing.
Role of the funding source. The study sponsor had
no role in the collection, analysis, and interpretation of
s 2
69)
Class 3
(n  196)
Class 4
(n  558)
Class 5
(n  111)
Class 6
(n  35)
13.2 53.3  14.2 59.3  11.4 62.3  10.9 63.0  10.7
85 74 70 49
23 37 48 46
45 33 36 31
27 26 10 17
5 4 6 6
4.3 27.0  4.7 27.1  5.1 28.6  5.2 31.1  7.3
19 29 29 33
51 46 56 49
30 15 15 18
4 1 1 0
17 11 6 7
15 12 8 13
64 76 85 80
42 50 55 47
35 39 42 56
20 31 39 38Clas
n  3
.5 
75
29
43
23
5
4.7 
17
54
29
2
20
20
58
37
22
16
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submit the paper for publication.
RESULTS
There were 1531 patients enrolled in the VEINES: 593
in France, 484 in Belgium, 359 in Italy, and 95 in Canada.
Characteristics of the study participants are shown in Table
I. Although male patients and all patients with active leg
ulcers were intentionally oversampled from the registration
population, the final VEINES population was predomi-
nantly comprised of women, and fewer than 10% of patients
had active or healed ulcers. Most patients had longstanding
CVD.
On the basis of the baseline clinical examination, pa-
tients were categorized into one of seven CEAP clinical
classes. The distribution of CEAP clinical class in the study
population is shown in Fig 1. Most patients were clustered
into CEAP classes 1 through 4. Characteristics of the study
population by CEAP category are shown in Table II. Mean
Fig 2. Box plots of quality of life scores by CEAP clinic
Short-Form Health Survey (SF-36) Physical Compon
Summary score (MCS). C, VEINES QOL score. D, VEIN
quality. For SF-36 PCS and MCS, data available for 13
Sym, data available for 1436 (93.8%) and 1422 (92.9%)
 .29; SF-36 PCS, P .0001; VEINES-QOL, P .000
lines, median score; boxes, interquartile range; lines aboveage, mean BMI, number of years since onset of CVD, and
prevalence of edema-related, arthrosis-related, or other co-
morbidity increased with higher CEAP class, whereas level
of education decreased with higher CEAP class.
QOL scores by CEAP class are shown in Fig 2. Mean
SF-36 PCS, VEINES-QOL and VEINES-Sym scores de-
creased significantly (ie, poorer QOL) with increasing
CEAP class (P  .0001, P  .0001, P  .0001 for trend,
respectively). However, there was no association between
SF-36 MCS scores and CEAP class (P .29). QOL scores
for subgroups are presented in Table III. Overall, SF-36
PCS, VEINES-QOL, and VEINES-Sym scores decreased
significantly with increasing age, number of years since
CVD onset, higher BMI, and lower level of education. The
presence of edema-related, arthrosis-related, or other co-
morbidity was also associated with poorer QOL. Overall,
patients from Belgium and France reported poorer QOL
than did patients from Italy or Canada. Female patients
s. Higher class, more severe clinically assessed CVD. A,
ummary score (PCS). B, SF-36 Mental Component
Sym. For all QOL measures, lower scores indicate poorer
6.2%) study subjects; for VEINES-QOL and VEINES-
subjects, respectively. P value for trend: SF-36 MCS, P
INES-Sym, P .0001., Mean QOL score; horizontal
below boxes, range.al clas
ent S
ES-
20 (8
study
1; VE
and
nt Sum
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specific QOL (VEINES-QOL) than did male patients.
Multivariable regression analyses, adjusting for age,
sex, country, BMI, comorbidity, level of education, and
years since onset of CVD, showed that progressively higher
CEAP class was an independent predictor of poorer
VEINES-QOL (P .0001) and VEINES-Sym scores (P
.003), but not SF-36 PCS or MCS scores (P .35 and P
.61, respectively). On the basis of the parameter estimates
obtained with our models, mean adjusted VEINES-QOL
scores for patients with CEAP class 0 would be reduced (ie,
worse) by 2% for CEAP class 1, 4% for CEAP class 3, and 9%
for CEAP class 6; for VEINES-Sym, scores would be
reduced by 3%, 6%, and 8%, respectively.
DISCUSSION
We found that clinically assessed CEAP class was signif-
icantly associated with generic and venous disease–specific
QOL. After adjustment for confounding variables, CEAP
class predicted disease-specific but not generic QOL.
CEAP class was not associated with the SF-36 MCS at
either univariate or multivariate analyses.
Table III. Quality of life scores by subgroups
Variable VEINES-QOL P VEI
Sex
Male 50.9  5.8 50
Female 49.7  6.1 .002 49
Age (y)
40 52.0  4.9 51
41-65 49.9  6.0 49
65 48.6  6.3 .000 49
Country
Belgium 48.9  6.8 49
France 49.6  5.7 49
Italy 51.0  6.3 51
Quebec 52.9  4.9 .000 52
Body mass index (kg/m)2
26 51.4  5.4 51
26-29 49.7  6.0 49
29 47.1  6.2 .000 47
Education
Grade school 48.4  6.3 48
High school 49.8  6.0 49
College or higher 51.4  5.1 .000 51
Years since onset of CVD
1 52.3  6.8 51
1-4 51.2  5.5 50
5-9 50.7  5.7 50
9 49.4  6.7 .000 49
Edema-related comorbidity
No 50.8  5.7 50
Yes 48.2  6.2 .000 48
Arthroses-related comorbidity
No 50.9  6.4 50
Yes 46.9  6.3 .000 46
Other comorbidity
No 50.9  5.7 51
Yes 48.6  6.1 .000 48
Values represent mean  SD.
VEINES, Venous Insufficiency Epidemiologic and Economic Study; QOL, Q
items; PCS, Physical Component Summary Score; MCS, Mental ComponeOur findings are important for a number of reasons.
First, they indicate that the CEAP clinical classification,
which is based on physicians’ assessments, also reflects
patients’ perceptions of CVD severity. These findings
therefore provide new evidence about the validity of CEAP,
which, although widely adopted by physicians in the field,
has not been formally validated.12 Second, our results
emphasize that CVD has a graded, adverse effect on QOL.
As a reference point, SF-36 PCS scores among patients in
CEAP class 5 and 6 are similar to those previously reported
for patients with chronic obstructive pulmonary disease,
osteoarthritis, or angina.10 This supports the need for
further research to evaluate preventive and therapeutic
interventions to reduce the burden of CVD. Third, we
found that after adjustment for confounding variables,
higher CEAP class was associated with poorer disease-
specific QOL, but not generic QOL. This provides further
evidence of the validity of the VEINES-QOL and
VEINES-Sym and the specificity of CEAP in terms of
detecting morbidity directly attributable to CVD and not
to other comorbid conditions or patient characteristics.
Finally, we showed that the variables of age, sex, duration of
-Sym P SF-36 PCS P SF-36 MCS P
6.3 45.5  9.4 46.2  9.5
6.8 .10 45.3  9.9 .68 43.4  11.3 .000
4.9 50.3  8.3 43.4  10.5
6.0 45.9  9.2 44.1  11.2
6.3 .000 40.2  9.8 .000 44.5  11.0 .44
6.8 43.1  10.4 42.9  11.3
6.3 45.4  9.4 42.7  11.0
7.0 46.7  9.3 46.6  10.2
6.0 .000 51.1  7.7 .000 49.0  9.5 .000
6.3 48.5  8.6 43.9  10.9
6.6 44.3  9.8 44.2  11.2
6.7 .000 39.1  9.7 .000 44.1  11.1 .91
6.8 42.8  9.3 43.7  10.8
6.8 44.4  9.8 4.2  11.1
6.1 .000 48.4  9.5 .000 44.5  10.9 .58
6.9 49.1  9.3 47.0  10.6
6.0 47.6  9.0 43.3  11.1
6.6 47.3  9.2 43.4  10.7
6.7 .02 44.4  9.8 .000 44.3  11.1 .30
6.5 47.0  9.1 44.0  10.9
6.9 .000 41.6  10.3 .000 44.1  11.2 .92
6.4 47.3  9.0 44.2  10.9
6.8 .000 38.7  9.6 .000 43.7  11.3 .50
5.7 47.8  9.0 44.7  10.8
6.1 .000 41.8  9.9 .000 43.2  11.2 .02
y of Life Score; Sym, Symptom Score; SF-36, Short-Form Health Survey, 36
mary Score.NES
.5 
.8 
.9 
.6 
.1 
.0 
.8 
.6 
.5 
.4 
.6 
.1 
.4 
.7 
.2 
.8 
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various comorbid conditions were associated with QOL
scores and with CEAP class. Hence we have identified
important confounding variables that need to be consid-
ered in future studies of patients with CVD.
To our knowledge, no other study has examined the
relationship between CEAP clinical class and QOL, al-
though our group recently showed that in patients with
varicose veins impairment in QOL is attributable to con-
comitant venous disease rather than to the presence of
varicose veins per se.13 A recent cross-sectional study of 872
patients with CVD showed that the proportion of patients
with any venous symptom, recorded as present or absent,
increased with higher CEAP clinical class. However, QOL
and symptom severity were not studied.14 Our study was
carried out before the development of the Venous Clinical
Severity Score (VCSS), a 30-point scoring instrument in-
tended to complement CEAP in assessing change in severity
of CVD over time.15 Although a recent study showed a good
correlation between VCSS and CEAP,16 the VCSS addresses
the presence and severity of only one symptom, pain. Our
findings that patients with higher CEAP class showed
poorer SF-36 PCS, and VEINES-QOL and VEINES-Sym
scores, but not SF-36 MCS scores, confirm results in a
recent study of patients with deep venous thrombosis.17
Our study cohort was large, international, and ran-
domly sampled from almost 6000 consecutive patients with
symptoms or signs of CVD. Nevertheless, it is important to
consider study limitations. By design, we intentionally
oversampled the source population for male patients and
patients with ulcers, to ensure adequate numbers of these
patients for the VEINES analyses; hence such patients were
overrepresented in the final study population. It is possible
that this could affect the generalizability of our results to
these groups. Although the same cohort of patients was
used to validate the VEINES-QOL and VEINES-Sym
questionnaire and to investigate the relationship between
QOL and clinical severity as measured with the CEAP, our
results provide further validity evidence for both the clinical
and patient-based measures. We did not systematically col-
lect data on the cause of venous disease, its anatomic extent,
or physiologic features, which would have been useful to
more comprehensively characterize CVD in our patients.
Finally, there may be additional important confounding
variables that were not assessed in our baseline questionnaire.
In conclusion, we found that, in a large international
cohort of patients with CVD, physician-assessed CEAP
clinical class was associated with patient-reported QOL,
even after adjustment for confounders.
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